Skip to main content
All lobbying clients

NOVARTIS

Lobbying client · District of Columbia · filed 2025 to 2026

$13,128,000 Reported spend
6 Filings counted
1 Firms hired
30 Bills named

Spend is reported income plus in-house expenses across 6 filings. 2 further filings on this record were restated by a later amendment and are left out of every total here. Everything on this page is grouped by the client's LDA id (113305), not by name.

 Firms hired 1
 Bills named in these filings 30
  • HR 1262
    Mikaela Naylon Give Kids a Chance Act
    6 filings
  • HR 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…
    6 filings
  • HR 1672
    Maintaining Investments in New Innovation Act
    6 filings
  • HR 2214
    DRUG Act
    6 filings
  • HR 946
    ORPHAN Cures Act
    6 filings
  • HR 950
    Saving Seniors Money on Prescriptions Act
    6 filings
  • S 1041
    Affordable Prescriptions for Patients Act
    6 filings
  • S 1095
    Stop STALLING Act
    6 filings
  • S 1096
    Preserve Access to Affordable Generics and Biosimilars Act
    6 filings
  • S 1097
    Interagency Patent Coordination and Improvement Act of 2025
    6 filings
  • S 832
    EPIC Act of 2025
    6 filings
  • S 864
    HELP Copays Act
    6 filings
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
    5 filings
  • HR 3037
    Access to Breast Cancer Diagnosis Act of 2025
    5 filings
  • HR 3152
    Patent Eligibility Restoration Act of 2025
    5 filings
  • HR 3160
    PREVAIL Act
    5 filings
  • HR 3269
    ETHIC Act
    5 filings
  • S 1500
    Access to Breast Cancer Diagnosis Act of 2025
    5 filings
  • S 43
    Skinny Labels, Big Savings Act
    5 filings
  • HR 2425
    National Poverty Research Center Authorization Act
    4 filings
  • HR 5256
    340B ACCESS Act
    4 filings
  • S 2276
    ETHIC Act
    4 filings
  • S 932
    Give Kids a Chance Act of 2025
    4 filings
  • HR 5371
    Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and E…
    3 filings
  • S 1682
    Alex Gate Safety Act of 2025
    3 filings
  • HR 5391
    Protecting Patient Access to Cancer and Complex Therapies Act
    2 filings
  • S 2764
    Protecting Patient Access to Cancer and Complex Therapies Act of 2023
    2 filings
  • HR 2425
    Kairo Act of 2025
    2 filings
  • HR 7148
    Consolidated Appropriations Act, 2026
    2 filings
  • HR 8800
    National Defense Authorization Act for Fiscal Year 2027
    1 filing
 Reported by year 2 years
  • 2026 $5,340,000 2 filings
  • 2025 $7,788,000 4 filings
 Issues lobbied 7

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 16
  • Centers For Medicare and Medicaid Services (CMS) 6
  • Commerce, Dept of (DOC) 6
  • Congressional Budget Office (CBO) 6
  • Executive Office of the President (EOP) 6
  • Food & Drug Administration (FDA) 6
  • Health & Human Services, Dept of (HHS) 6
  • HOUSE OF REPRESENTATIVES 6
  • Office of Management & Budget (OMB) 6
  • Patent & Trademark Office (PTO) 6
  • SENATE 6
  • U.S. Trade Representative (USTR) 6
  • White House Office 6
  • Treasury, Dept of 4
  • Health Resources & Services Administration (HRSA) 1
  • State, Dept of (DOS) 1
  • U.S. Agency for International Development (USAID) 1

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem